All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| HZNP / Horizon Therapeutics Plc
|
|
|
|
|
|
|
|
| CALA / Calithera Biosciences, Inc.
|
|
|
|
|
|
|
|
| MRNS / Marinus Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
| ZYME / Zymeworks Inc.
|
|
|
|
|
|
|
|
| ETTX / Entasis Therapeutics Holdings Inc
|
|
|
|
|
|
|
|
| GWP / GW Pharmaceuticals plc
|
|
|
|
|
|
|
|
| RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
| SUPN / Supernus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| VYNE / VYNE Therapeutics Inc.
|
|
|
|
|
|
|
|
| KDMN / Kadmon Holdings Inc
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
| OEF / iShares Trust - iShares S&P 100 ETF Put
|
|
|
|
|
|
|
|
| AMGN / Amgen Inc.
|
|
|
|
|
|
|
|
| Nucana Biomed Ltd
/ Ordinary Shares (GBOOBYWYV) |
|
|
|
|
|
|
|
| MRNA / Moderna, Inc. Call
|
|
|
|
|
|
|
|
| US62857M1053 / MyoKardia, Inc.
|
|
|
|
|
|
|
|
| OVID / Ovid Therapeutics Inc.
|
|
|
|
|
|
|
|
| US2103731061 / Constellation Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| 48283N114 / Kadmon Warrants Exp. 09/29/2022
|
|
|
|
|
|
|
|
| LQDA / Liquidia Corporation
|
|
|
|
|
|
|
|
| ATHA / Athira Pharma, Inc.
|
|
|
|
|
|
|
|
| AGTC / Applied Genetic Technologies Corp
|
|
|
|
|
|
|
|
| ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
| MRSN / Mersana Therapeutics, Inc.
|
|
|
|
|
|
|
|
| Invesco QQQ Trust
/ UNIT SER 1 Put (46090E953) |
|
|
|
|
|
|
|
| ORIC / ORIC Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SPDR Ser Tr
/ S&P Biotech Put (78464A950) |
|
|
|
|
|
|
|
| CYTK / Cytokinetics, Incorporated Put
|
|
|
|
|
|
|
|
| AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PBYI / Puma Biotechnology, Inc.
|
|
|
|
|
|
|
|
| XLB / The Select Sector SPDR Trust - The Materials Select Sector SPDR Fund Put
|
|
|
|
|
|
|
|
| US74257L1089 / Principia Biopharma Inc.
|
|
|
|
|
|
|
|
| BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
| KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
| AMGN / Amgen Inc. Call
|
|
|
|
|
|
|
|
| OBSV / ObsEva SA.
|
|
|
|
|
|
|
|
| US16706W1027 / Chiasma Inc
|
|
|
|
|
|
|
|
| FIXX / Homology Medicines, Inc.
|
|
|
|
|
|
|
|
| JAZZ / Jazz Pharmaceuticals plc
|
|
|
|
|
|
|
|
| NTLA / Intellia Therapeutics, Inc.
|
|
|
|
|
|
|
|
| XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
| ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| PDSB / PDS Biotechnology Corporation
|
|
|
|
|
|
|
|
| KALA / KALA BIO, Inc.
|
|
|
|
|
|
|
|
| AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| MRUS / Merus N.V.
|
|
|
|
|
|
|
|
| ITCI / Intra-Cellular Therapies, Inc.
|
|
|
|
|
|
|
|
| ITCI / Intra-Cellular Therapies, Inc. Put
|
|
|
|
|
|
|
|
| AKBA / Akebia Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AKUS / Akouos Inc
|
|
|
|
|
|
|
|
| TCRR / Tcr2 Therapeutics Inc
|
|
|
|
|
|
|
|
| OTIC / Otonomy Inc
|
|
|
|
|
|
|
|
| AMGN / Amgen Inc. Put
|
|
|
|
|
|
|
|
| APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CMPI / Checkmate Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| CGEN / Compugen Ltd.
|
|
|
|
|
|
|
|
| FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
| GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
| RETA / Reata Pharmaceuticals Inc - Class A
|
|
|
|
|
|
|
|
| PFE / Pfizer Inc. Call
|
|
|
|
|
|
|
|
| MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
| NCNA / NuCana plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
| CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
| PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
| YMAB / Y-mAbs Therapeutics, Inc.
|
|
|
|
|
|
|
|
| UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
| SVRA / Savara Inc.
|
|
|
|
|
|
|
|
| PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PTCT / PTC Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
| NXTC / NextCure, Inc.
|
|
|
|
|
|
|
|
| MIRM / Mirum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| IMVT / Immunovant, Inc.
|
|
|
|
|
|
|
|
| BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| KRTX / Karuna Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NVCR / NovoCure Limited Call
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
|
|
|
|
|
|
| SYBX / Synlogic, Inc.
|
|
|
|
|
|
|
|
| INZY / Inozyme Pharma, Inc.
|
|
|
|
|
|
|
|
| LLY / Eli Lilly and Company
|
|
|
|
|
|
|
|
| INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
| SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| RETA / Reata Pharmaceuticals Inc - Class A Put
|
|
|
|
|
|
|
|
| IMTX / Immatics N.V.
|
|
|
|
|
|
|
|
| GRTX / Galera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
